Glenmark Therapeutics Inc. USA launches Olopatadine Hydrochloride Ophthalmic Solution USP 0.1% (OTC)
Recently Viewed
Clear All
19-Aug-2024 Glenmark Pharmaceuticals
Glenmark Therapeutics Inc. USA launches Olopatadine Hydrochloride Ophthalmic Solution USP 0.1% (OTC)